Shenzhen Glory Medical Co.,Ltd. (SHE:002551)
China
· Delayed Price · Currency is CNY 3.800
+0.070 (1.88%)
Mar 10, 2026, 9:45 AM CST
Shenzhen Glory Medical Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 3,150 | 2,599 | 3,430 | 3,928 | 4,806 | 5,332 | Upgrade
|
| Market Cap Growth | 11.43% | -24.22% | -12.68% | -18.27% | -9.86% | 63.47% | Upgrade
|
| Enterprise Value | 2,597 | 2,114 | 2,940 | 3,669 | 4,656 | 5,245 | Upgrade
|
| Last Close Price | 3.73 | 3.07 | 4.05 | 4.64 | 5.68 | 6.49 | Upgrade
|
| PE Ratio | - | 116.64 | - | - | 107.94 | 32.88 | Upgrade
|
| Forward PE | - | 20.00 | 20.00 | 20.00 | 20.00 | 20.00 | Upgrade
|
| PS Ratio | 2.63 | 1.80 | 2.88 | 3.08 | 2.68 | 2.35 | Upgrade
|
| PB Ratio | 1.15 | 0.94 | 1.25 | 1.31 | 1.40 | 1.46 | Upgrade
|
| P/TBV Ratio | 1.37 | 1.11 | 1.47 | 1.76 | 1.87 | 1.98 | Upgrade
|
| P/FCF Ratio | - | 66.98 | - | 100.33 | - | 21.91 | Upgrade
|
| P/OCF Ratio | 72.29 | 21.49 | 194.50 | 40.73 | 19.81 | 10.72 | Upgrade
|
| PEG Ratio | - | 1.12 | 1.12 | 1.12 | 1.12 | 1.12 | Upgrade
|
| EV/Sales Ratio | 2.17 | 1.46 | 2.47 | 2.88 | 2.60 | 2.31 | Upgrade
|
| EV/EBITDA Ratio | 28.10 | 17.81 | - | - | 32.16 | 11.51 | Upgrade
|
| EV/EBIT Ratio | - | 129.91 | - | - | 68.36 | 13.09 | Upgrade
|
| EV/FCF Ratio | -86.80 | 54.48 | - | 93.71 | - | 21.55 | Upgrade
|
| Debt / Equity Ratio | 0.03 | 0.10 | 0.11 | 0.11 | 0.11 | 0.13 | Upgrade
|
| Debt / EBITDA Ratio | 0.85 | 2.27 | - | - | 2.71 | 1.05 | Upgrade
|
| Debt / FCF Ratio | - | 6.94 | - | 8.48 | - | 1.97 | Upgrade
|
| Net Debt / Equity Ratio | -0.25 | -0.24 | -0.19 | -0.20 | -0.20 | -0.21 | Upgrade
|
| Net Debt / EBITDA Ratio | -7.48 | -5.69 | 34.12 | 52.96 | -4.81 | -1.72 | Upgrade
|
| Net Debt / FCF Ratio | 23.10 | -17.40 | 21.59 | -15.02 | 3.72 | -3.22 | Upgrade
|
| Asset Turnover | 0.32 | 0.37 | 0.29 | 0.28 | 0.36 | 0.46 | Upgrade
|
| Inventory Turnover | 3.49 | 3.79 | 2.63 | 2.73 | 4.17 | 6.33 | Upgrade
|
| Quick Ratio | 1.87 | 1.65 | 1.70 | 1.71 | 1.76 | 2.03 | Upgrade
|
| Current Ratio | 2.26 | 1.95 | 2.20 | 2.30 | 2.19 | 2.51 | Upgrade
|
| Return on Equity (ROE) | -1.00% | 0.94% | -5.60% | -10.20% | 2.07% | 11.45% | Upgrade
|
| Return on Assets (ROA) | -0.25% | 0.26% | -1.70% | -1.85% | 0.85% | 5.12% | Upgrade
|
| Return on Invested Capital (ROIC) | -0.73% | 0.58% | -4.81% | -5.29% | 2.40% | 14.44% | Upgrade
|
| Return on Capital Employed (ROCE) | -0.50% | 0.60% | -3.60% | -4.00% | 1.80% | 10.00% | Upgrade
|
| Earnings Yield | -0.88% | 0.86% | -4.34% | -7.84% | 0.93% | 3.04% | Upgrade
|
| FCF Yield | -0.95% | 1.49% | -0.71% | 1.00% | -3.90% | 4.56% | Upgrade
|
| Dividend Yield | 0.21% | 0.26% | - | - | - | - | Upgrade
|
| Payout Ratio | - | 49.52% | - | - | 68.03% | 30.70% | Upgrade
|
| Buyback Yield / Dilution | 13.41% | -4.64% | -0.03% | 2.86% | -3.89% | 0.97% | Upgrade
|
| Total Shareholder Return | 13.63% | -4.38% | -0.03% | 2.86% | -3.89% | 0.97% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.